Corporate ActionJun 29, 2026, 04:33 PM
Jin Medical to Vote on Acquisition, Capital Increase, Voting Rights
AI Summary
Jin Medical International Ltd. will hold shareholder meetings on July 9, 2026, to approve several significant corporate actions. Key proposals include the acquisition of Beijing Tongsheng Technology Co., Ltd. for 64,186,456 Class A shares, a substantial increase in authorized share capital from $50,000 to $15,005,000, and a significant change in Class B ordinary share voting rights from 30 to 800 votes per share. Additionally, the company plans to repurchase Class A shares from its CEO's entity, Jolly Harmony, and issue Class B shares in exchange, further consolidating control.
Key Highlights
- Shareholders to vote on acquisition of Beijing Tongsheng Technology Co., Ltd.
- 64,186,456 Class A shares to be issued for Tongsheng acquisition at $1.641 per share.
- Authorized share capital to increase from $50,000 to $15,005,000.
- 14,955,000,000 new Class A ordinary shares to be created.
- Class B ordinary share voting rights to increase from 30 to 800 votes per share.
- Company to repurchase 3,769,057 Class A shares from Jolly Harmony.
- Company to issue 3,769,057 Class B shares to Jolly Harmony.
- Adoption of Third Amended and Restated Memorandum and Articles of Association.
Price Impact
More from ZJYL